Gambaran Kipi (Kejadian Ikutan Pasca Imunisasi) Pada Karyawan Rumah Sakit yang Mendapatkan Imunisasi Dengan Vaksin Sinovac di RSUD Kota Yogyakarta
Adriyanto Rochmad Basuki(1*), Gita Mayasari(2), Esti Handayani(3)
(1) Instalasi Farmasi RSUD Kota Yogyakarta
(2) Instalasi Farmasi RSUD Kota Yogyakarta
(3) Instalasi Farmasi RSUD Kota Yogyakarta
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Sanyaolu A, Okorie C, Hosein Z, et al. Global Pandemicity of COVID-19: Situation Report as of June 9, 2020. Infect Dis Res Treat. 2021;14:117863372199126. doi:10.1177/1178633721991260 Ophinni Y, Hasibuan AS, Widhani A, Maria S. COVID-19 Vaccines : Current Status and Implication for Use in Indonesia. Indones J Int Med. 2021;52(4):388-412. Rahman S, Montero MTV, Rowe K, Kirton R, Kunik F. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol. 2021;14(5):601-621. doi:10.1080/17512433.2021.1902303 Dawood FS, Ricks P, Njie GJ, et al. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. Lancet Infect Dis. 2020;20(11):1255-1262. doi:10.1016/S1473-3099(20)30581-8 Sharma O, Sultan AA, Ding H, Triggle CR. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Front Immunol. 2020;11(December 2019):1-17. doi:10.3389/fimmu.2020.585354 Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms underlying disease severity and progression. Physiology. 2020;35(5):288-301. doi:10.1152/physiol.00019.2020 Kadkhoda K. Herd Immunity to COVID-19. Am J Clin Pathol. 2021;155(4):471-472. doi:10.1093/ajcp/aqaa272 Ngadi N, Meliana R, Purba YA. Dampak Pandemi Covid-19 Terhadap Phk Dan Pendapatan Pekerja Di Indonesia. J Kependud Indones. 2020;2902:43. doi:10.14203/jki.v0i0.576 Seyed E, Riahi N, Nikzad H. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Virology. 2020;551(January):1-9. Or Caspi, Michael J. Smart RBN. Herd immunity: Understanding Covid-19 by Haley etal. Ann Oncol. 2020;(January):19-21. Speiser DE, Bachmann MF. Covid-19: Mechanisms of vaccination and immunity. Vaccines. 2020;8(3):1-22. doi:10.3390/vaccines8030404 Shervani Z, Khan I, Khan T, Qazi UY. COVID-19 Vaccine. Adv Infect Dis. 2020;10(03):195-210. doi:10.4236/aid.2020.103020 Peraturan Menteri Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 84 tahun 2020 tentang Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi. 2020;2019:4. Permenkes 65 tahun. Berita Negara. Menteri Kesehat Republik Indones Peratur Menteri Kesehat Republik Indones. 2015;Nomor 65(879):2004-2006. WHO Strategic Advisory Group of Experts (SAGE) on Immunisation. Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine. Published online 2021:32. https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage29apr2021_critical-evidence_sinovac.pdf?sfvrsn=2488098d_5 Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised,double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181-192. doi:10.1016/S1473-3099(20)30843-4 Han B, Song Y, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;3099(21):1-9. doi:10.1016/s1473-3099(21)00319-4 Kaur RJ, Dutta S, Bhardwaj P, et al. Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review. Indian J Clin Biochem. Published online 2021. doi:10.1007/s12291-021-00968-z WHO. Annexes To The Recommendations For Use Of The Janssen AD26.COV2.S Vaccine Against COVID-19. World Heal Organ. 2021;(March):1-32. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-Sinovac-CoronaVac-annexes-2021.1
DOI: https://doi.org/10.22146/farmaseutik.v18i1.71908
Article Metrics
Abstract views : 8465 | views : 10726Refbacks
- There are currently no refbacks.